|Articles|August 9, 2019
Requirements for Fully Integrated Service Offerings in a HPAPI and Cytotoxic Environment
Author(s)Lonza
• Advantages of using an integrated-service provider • Case study: HPAPI monoplant
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
